Assertio Holdings Inc
NASDAQ:ASRT
Assertio Holdings Inc
Cash from Operating Activities
Assertio Holdings Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Assertio Holdings Inc
NASDAQ:ASRT
|
Cash from Operating Activities
$49.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
18%
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Operating Activities
$23.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Operating Activities
$13.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
12%
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Operating Activities
$8.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Operating Activities
$13B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
See Also
What is Assertio Holdings Inc's Cash from Operating Activities?
Cash from Operating Activities
49.6m
USD
Based on the financial report for Dec 31, 2023, Assertio Holdings Inc's Cash from Operating Activities amounts to 49.6m USD.
What is Assertio Holdings Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
18%
Over the last year, the Cash from Operating Activities growth was -37%.